日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

"Identification of Nafamostat and VR23 as COVID-19 drug candidates by targeting 3CL(pro) and PL(pro).".

“通过靶向 3CL(pro) 和 PL(pro) 鉴定出 Nafamostat 和 VR23 作为 COVID-19 候选药物”

Bhowmik Deep, Sharma Ravi Datta, Prakash Amresh, Kumar Diwakar

Evaluation of flavonoids as 2019-nCoV cell entry inhibitor through molecular docking and pharmacological analysis

通过分子对接和药理学分析评价黄酮类化合物作为2019-nCoV细胞进入抑制剂的活性

Bhowmik, Deep; Nandi, Rajat; Prakash, Amresh; Kumar, Diwakar

Identification of potential inhibitors against SARS-CoV-2 by targeting proteins responsible for envelope formation and virion assembly using docking based virtual screening, and pharmacokinetics approaches.

利用基于对接的虚拟筛选和药代动力学方法,通过靶向负责包膜形成和病毒颗粒组装的蛋白质,鉴定针对 SARS-CoV-2 的潜在抑制剂

Bhowmik Deep, Nandi Rajat, Jagadeesan Rahul, Kumar Niranjan, Prakash Amresh, Kumar Diwakar